Leigh Brody
Director/Board Member at Bloomsbury Genetic Therapies Ltd.
Profile
Leigh Brody is currently the Director at Bloomsbury Genetic Therapies Ltd.
and Investment Manager at Albion Capital Group LLP.
Brody holds a doctorate degree from Imperial College London and an undergraduate degree from Simmons University.
Leigh Brody active positions
Companies | Position | Start |
---|---|---|
Albion Capital Group LLP
Albion Capital Group LLP Investment ManagersFinance Albion Ventures LLP (Albion Ventures) is a venture capital firm founded in 1996. The firm is headquartered in London. | Private Equity Investor | 31/12/2020 |
Bloomsbury Genetic Therapies Ltd.
Bloomsbury Genetic Therapies Ltd. BiotechnologyHealth Technology Bloomsbury Genetic Therapies Ltd. is a British biotechnology company that specializes in developing gene therapy technologies for neurological and metabolic diseases. The company is based in Cambridge, UK. Bloomsbury Genetic Therapies was founded in 2021 by Adrien Lemoine, who has been the CEO since 2021. | Director/Board Member | 31/03/2022 |
Training of Leigh Brody
Simmons University | Undergraduate Degree |
Imperial College London | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Albion Capital Group LLP
Albion Capital Group LLP Investment ManagersFinance Albion Ventures LLP (Albion Ventures) is a venture capital firm founded in 1996. The firm is headquartered in London. | Finance |
Bloomsbury Genetic Therapies Ltd.
Bloomsbury Genetic Therapies Ltd. BiotechnologyHealth Technology Bloomsbury Genetic Therapies Ltd. is a British biotechnology company that specializes in developing gene therapy technologies for neurological and metabolic diseases. The company is based in Cambridge, UK. Bloomsbury Genetic Therapies was founded in 2021 by Adrien Lemoine, who has been the CEO since 2021. | Health Technology |
- Stock Market
- Insiders
- Leigh Brody